Start for free
Start for free
CS

CDP Sofinov

North America, Quebec, Canada, Montréal

Description

CDP Sofinov

Investor Profile

CDP Sofinov has made 6 investments, with 0 in the past 12 months and 17% as lead.

Stage Focus

  • Series B (33%)
  • Series Unknown (33%)
  • Series C (33%)

Country Focus

  • United States (67%)
  • Canada (33%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Information Technology
  • Software
  • Clinical Trials
  • Health Care
  • Crm
  • Marketing
  • Mobile
  • Network Security
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CDP Sofinov frequently co-invest with?

T2C2 Capital
T2C2 Capital
North America, Quebec, Canada, Montréal
Co-Investments: 1
Canadian Medical Discoveries Fund
Canadian Medical Discoveries Fund
North America, Nova Scotia, Canada, Halifax
Co-Investments: 1
CC
Capital Communications CDPQ
North America, Quebec, Canada, Montréal
Co-Investments: 1
Agilent Technologies
Agilent Technologies
North America, California, United States, Santa Clara
Co-Investments: 1
BDC Venture Capital
BDC Venture Capital
North America, Alberta, Canada, Calgary
Co-Investments: 1
CS
Cabletron Systems
North America, New Hampshire, United States, Rochester
Co-Investments: 1
Business Development Bank of Canada
Business Development Bank of Canada
North America, Quebec, Canada, Montréal
Co-Investments: 1
Novo Holdings
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
VentureLink LP
VentureLink LP
North America, Ontario, Canada, Toronto
Co-Investments: 1
GeneChem
GeneChem
North America, Quebec, Canada, Montréal
Co-Investments: 1

Which angels does CDP Sofinov often collaborate with?

JC
Jay Chaudhry
North America, California, United States, San Jose
Shared Deals: 1

What are some of recent deals done by CDP Sofinov?

Inhibitex

Alpharetta, Georgia, United States

Inhibitex is a clinical-stage biopharmaceutical company that develops treatments for bacterial and viral infections.

BiotechnologyHealth CarePharmaceutical
Series UnknownFeb 11, 2002
Amount Raised: $20,000,000
Cytochroma

Kingston, Ontario, Canada

Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat

BiotechnologyClinical TrialsPharmaceutical
Series BDec 18, 2001
Amount Raised: $2,226,803
Air2Web

Atlanta, Georgia, United States

Air2Web provides solutions that enable companies to promote products, optimize their customer service and enable mobile transactions.

CRMInformation TechnologyMarketingMobile
Series COct 10, 2001
Amount Raised: $25,000,000
NETdelivery

Boulder, Colorado, United States

Develops software to allow secure collection, distribution and management.

Network SecuritySecuritySoftware
Series CJul 31, 2001
Amount Raised: $22,800,000
Spike Broadband Systems

Nashua, New Hampshire, United States

Spike Broadband Systems is a provider of carrier-grade and fixed wireless services.

Information Technology
Series UnknownNov 14, 2000
Amount Raised: $47,000,000
eSignLive by VASCO

Montréal, Quebec, Canada

eSignLive e-signatures are white labelled behind some of the world's most trusted brands and known as a leader alongside DocuSign and Adobe.

BankingInsuranceSoftware
Series BSep 26, 2000
Amount Raised: $11,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator